William Blair analyst Alethia Young initiates coverage on Faeth Therapeutics (NASDAQ: FTH) with a Outperform rating.The analyst comments: “We are ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage